Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
Article in Microbiome Research Reports (September 2023)
The most recent citing publications are shown below. View all 70 publications that cite this research output on Dimensions.
Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease
Article in Frontiers in Microbiology (February 2023)
Nucleopeptide-Coupled Injectable Bioconjugated Guanosine-Quadruplex Hydrogel with Inherent Antibacterial Activity
Article in ACS Applied Bio Materials (January 2023)